Mesa Laboratories, Inc. $MLAB Shares Sold by Ranger Investment Management L.P.

Ranger Investment Management L.P. reduced its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 7.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 214,290 shares of the medical instruments supplier's stock after selling 16,698 shares during the quarter. Ranger Investment Management L.P. owned 3.89% of Mesa Laboratories worth $20,190,000 at the end of the most recent quarter.Get Mesa Laboratories alerts:A number of other institutional investors also recently added to or reduced their stakes in MLAB. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Mesa Laboratories by 4.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,068 shares of the medical instruments supplier's stock valued at $364,000 after purchasing an additional 143 shares during the period. Franklin Resources Inc. grew its position in Mesa Laboratories by 5.5% in the 2nd quarter. Franklin Resources Inc. now owns 3,476 shares of the medical instruments supplier's stock valued at $328,000 after buying an additional 182 shares in the last quarter. American Century Companies Inc. increased its stake in Mesa Laboratories by 1.5% during the 2nd quarter. American Century Companies Inc. now owns 13,431 shares of the medical instruments supplier's stock valued at $1,265,000 after buying an additional 194 shares during the period. State of Alaska Department of Revenue raised its position in shares of Mesa Laboratories by 7.1% during the 2nd quarter. State of Alaska Department of Revenue now owns 3,224 shares of the medical instruments supplier's stock worth $303,000 after buying an additional 213 shares in the last quarter. Finally, Royal Bank of Canada lifted its stake in shares of Mesa Laboratories by 1.2% in the 1st quarter. Royal Bank of Canada now owns 30,772 shares of the medical instruments supplier's stock worth $3,652,000 after acquiring an additional 353 shares during the period. Institutional investors and hedge funds own 90.60% of the company's stock. Mesa Laboratories Trading Down 1.1%Mesa Laboratories stock opened at $77.77 on Friday. The firm has a market cap of $429.29 million, a price-to-earnings ratio of -243.03 and a beta of 0.90. Mesa Laboratories, Inc. has a 1 year low of $55.45 and a 1 year high of $155.12. The firm's 50 day moving average price is $75.50 and its two-hundred day moving average price is $77.92. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.44 and a current ratio of 2.02. Mesa Laboratories Dividend AnnouncementThe business also recently declared a quarterly dividend, which will be paid on Monday, December 15th. Investors of record on Friday, November 28th will be given a $0.16 dividend. The ex-dividend date is Friday, November 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.8%. Mesa Laboratories's dividend payout ratio (DPR) is -200.00%. Wall Street Analysts Forecast GrowthA number of research analysts recently commented on MLAB shares. Wall Street Zen upgraded shares of Mesa Laboratories from a "hold" rating to a "buy" rating in a research note on Saturday, November 8th. Weiss Ratings reiterated a "sell (d)" rating on shares of Mesa Laboratories in a research report on Wednesday, October 8th. Finally, Zacks Research upgraded Mesa Laboratories to a "strong sell" rating in a report on Thursday. One investment analyst has rated the stock with a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Mesa Laboratories currently has an average rating of "Sell" and a consensus target price of $67.00.Get Our Latest Stock Analysis on Mesa LaboratoriesMesa Laboratories Profile (Free Report)Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.See AlsoFive stocks we like better than Mesa LaboratoriesDifferences Between Momentum Investing and Long Term Investing Disney's $1 Billion Deal Brings Its Magic to OpenAIThe Risks of Owning BondsWhy Amazon Could Be a $300 Stock Within WeeksUpcoming IPO Stock Lockup Period, ExplainedAdobe Gets Post-Earnings Lift: Long-Term Outlook Favors UpsideThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Mesa Laboratories Right Now?Before you consider Mesa Laboratories, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mesa Laboratories wasn't on the list.While Mesa Laboratories currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here